134 related articles for article (PubMed ID: 29046905)
41. Sonic hedgehog regulation of
Everson JL; Fink DM; Yoon JW; Leslie EJ; Kietzman HW; Ansen-Wilson LJ; Chung HM; Walterhouse DO; Marazita ML; Lipinski RJ
Development; 2017 Jun; 144(11):2082-2091. PubMed ID: 28506991
[TBL] [Abstract][Full Text] [Related]
42. Transcription factor FOXF1 regulates growth hormone variant gene expression.
Lomenick JP; Hubert MA; Handwerger S
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E947-51. PubMed ID: 16772323
[TBL] [Abstract][Full Text] [Related]
43. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway.
Zhang J; Zhang C; Sang L; Huang L; Du J; Zhao X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30249755
[TBL] [Abstract][Full Text] [Related]
44. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
[TBL] [Abstract][Full Text] [Related]
45. Cancer genetics and genomics of human FOX family genes.
Katoh M; Igarashi M; Fukuda H; Nakagama H; Katoh M
Cancer Lett; 2013 Jan; 328(2):198-206. PubMed ID: 23022474
[TBL] [Abstract][Full Text] [Related]
46. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
Nik AM; Reyahi A; Pontén F; Carlsson P
Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
[TBL] [Abstract][Full Text] [Related]
47. Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.
Kong PZ; Li GM; Tian Y; Song B; Shi R
Oncotarget; 2016 Aug; 7(34):55601-55610. PubMed ID: 27487137
[TBL] [Abstract][Full Text] [Related]
48. MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines.
Liang YK; Lin HY; Dou XW; Chen M; Wei XL; Zhang YQ; Wu Y; Chen CF; Bai JW; Xiao YS; Qi YZ; Kruyt FAE; Zhang GJ
NPJ Breast Cancer; 2018; 4():20. PubMed ID: 30109262
[TBL] [Abstract][Full Text] [Related]
49. FoxD3 deficiency promotes breast cancer progression by induction of epithelial-mesenchymal transition.
Chu TL; Zhao HM; Li Y; Chen AX; Sun X; Ge J
Biochem Biophys Res Commun; 2014 Apr; 446(2):580-4. PubMed ID: 24632201
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
Seok Y; Kang HG; Lee SY; Jeong JY; Choi JE; Jung DK; Jin CC; Hong MJ; Do SK; Lee WK; Park JY; Shin KM; Yoo SS; Lee J; Cho S; Cha SI; Kim CH; Jheon S; Lee EB; Park JY
Ann Surg Oncol; 2017 Oct; 24(11):3386-3395. PubMed ID: 28766235
[TBL] [Abstract][Full Text] [Related]
51. miR-130b participates in wear particle-induced inflammation and osteolysis via FOXF2/NF-κB pathway.
Zheng DZ; Bu YM; Wang L
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):408-414. PubMed ID: 30488739
[TBL] [Abstract][Full Text] [Related]
52. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
53. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
[TBL] [Abstract][Full Text] [Related]
54. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
[TBL] [Abstract][Full Text] [Related]
55. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
56. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
[TBL] [Abstract][Full Text] [Related]
57. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.
Zuo H; Yang Q
J BUON; 2018; 23(3):720-728. PubMed ID: 30003742
[TBL] [Abstract][Full Text] [Related]
58. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A; Jin C; Li H; Qin Q; Li L
Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
[TBL] [Abstract][Full Text] [Related]
59. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]